We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

C-Reactive Protein Assessed for Albuminuria Severity

By LabMedica International staff writers
Posted on 21 Feb 2018
Print article
Image: The Nephelometer analyzer BN II (Photo courtesy of Siemens Healthcare).
Image: The Nephelometer analyzer BN II (Photo courtesy of Siemens Healthcare).
Diabetes is a major cause of early morbidity and mortality in the world and is the leading cause of renal failure, non-traumatic amputations and blindness in adults. Chronic hyperglycemia causes irreversible structural and functional changes in cells leading to the development of microvascular and macrovascular complications.

C-reactive protein is one of the most sensitive markers of subclinical inflammation, and its serum concentration is an indicator of intensity of low-grade chronic inflammation of the arterial wall. Measurement of total albuminuria in 24-hour urine is the gold standard for early detection of nephropathy and its prevention and the most sensitive prognostic factor for assessing the risk of developing clinical nephropathy.

Scientists at Cantonal Hospital Zenica (Zenica, Bosnia and Herzegovina) and their colleagues carried out a prospective study included 69 patients with diabetes mellitus type 2 (T2DM), both sexes (24 males, 45 females), aged 30-82 years. They were divided into two groups: 40 patients with T2DM and normoalbuminuria (T2DM-NA); and 29 patients with T2DM and microalbuminuria (T2DM-MA). Patients were hospitalized at the Department of Internal Medicine, Cantonal Hospital Zenica, in the period January-April 2014.

Biochemical analyses were performed for serum creatinine, urea, high sensitive C-reactive protein (hsCRP), and albumin in 24-hour urine samples. Immunonephelometry measurement of hsCRP was performed on the Nephelometer Analyzer BN II. The 24 urinary albumin measurements were performed using immunoturbidimetric method (PETINIA), and the HbA1c was measured by turbidimetric inhibition immunoassay (TINIA) and an analysis was performed using the Siemens’ Dimension Clinical Chemistry System analyzer.

The team reported that the frequency of patients in T2DM-NA and T2DM-MA groups was not significantly different in relation to sex and age. There was significant difference in relation to duration of diabetes. The mean glucose and HbA1c levels were significantly higher in T2DM-NA group comparing to T2DM-MA group. Serum creatinine, urea and hsCRP were significantly higher in T2DM-MA group compared to T2DM-NA group. Urinary albumin showed significantly positive correlation with the hsCRP, urea and creatinine. A one unit (mg/L) increase in hsCRP concentration was associated with 11.5% increase of odds of microalbuminuria.

The authors concluded that significantly higher values of serum hsCRP in patients with type 2 diabetes mellitus and microalbuminuria in comparison to those with normoalbuminuria as well as the correlation of values of inflammatory marker with urinary albumin implicate a low-grade inflammation in the progression of diabetic nephropathy. The study was published on February 1, 2018, in the journal Medicinski Glasnik.

Related Links:
Cantonal Hospital Zenica

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: The study investigated D-dimer testing in patients who are at higher risk of pulmonary embolism (Photo courtesy of Adobe Stock)

D-Dimer Testing Can Identify Patients at Higher Risk of Pulmonary Embolism

Pulmonary embolism (PE) is a commonly suspected condition in emergency departments (EDs) and can be life-threatening if not diagnosed correctly. Achieving an accurate diagnosis is vital for providing effective... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Sekisui Diagnostics UK Ltd.